Clinical trial
Monoclonal Antibody CMV Retinitis Trial (MACRT)
NCT00000135 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monoclonal Antibody CMV Retinitis Trial (MACRT)
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 30, 1995
- Completion date
- August 31, 1996
- Enrollment
- 209 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.